A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Tricuspid Valve Repair Market to Witness Increased Revenue Growth Owing to Heightened Product Innovations – A Scrutinized Report by Fact.MR

Innovations in minimally invasive procedures are executed to spur the adoption of tricuspid valves. Artificial valves are gaining prominence as it is becoming increasingly feasible to solve fluid dynamics problems and simulate flow within an artificial heart valve. The availability of computational tools can also be used to approximate fluid mechanics parameters such as turbulence and regurgitation volumes and pressure drops. On the back of these aforementioned factors, the tricuspid valve repair market is estimated to grow at a dexterous CAGR of 10.0% during the forecast period (2019-2029).

For more insights, Request a Sample of Tricuspid Valve Repair Market Report https://www.factmr.com/connectus/sample?flag=S&rep_id=3416

Key Takeaways of Tricuspid Valve Repair Market Study

  • By product type, annuloplasty rings are primarily used in tricuspid valve repair. This is primarily attributed to the absence of other approved medical devices to repair tricuspid valves in the heart.
  • Germany and France will hold 13.1% and 11.1% of the global tricuspid valve repair share. Germany is anticipated to exhibit notable CAGR, owing to availability of approved products to treat tricuspid valve defects.
  • The hospitals segment has maintained its supremacy in the tricuspid valve repair market, which is attributed to the presence of state-of-the-art, cutting-edge technologies for tricuspid valve surgical procedures to treat tricuspid valve defects.

 “Increasing research & development funding and acquisition strategies adopted by major players to expand their regional presence is anticipated to favor the tricuspid valve repair market growth.” says the Fact.MR Analyst.       

Acquisition and Product Portfolio Expansion are the Key Strategies Followed by Market Players

Tricuspid valve repair device manufacturers are focusing on mergers and acquisitions, which can give them a broader spectrum of product offerings, enhanced capabilities, and large scale manufacturing. In 2017, Edwards Lifesciences acquired Israel based Valtech Cardio, a developer of Cardioband System for Transcatheter repair of mitral and tricuspid valves. With the growing investments in healthcare infrastructure and technological advancements, manufacturers are also focusing on research & development investments to innovate new procedures and medical devices used in tricuspid valve repair.

For comprehensive insights on this market adoption, ask an analyst here  https://www.factmr.com/connectus/sample?flag=AE&rep_id=3416

Looking for more information?

The research study on the tricuspid valve repair market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the tricuspid valve repair market over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 – 2029. Market statistics have been presented on the basis of product type (annuloplasty rings), Indication (tricuspid valve regurgitation, and tricuspid valve stenosis) and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories) across major countries of key regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Heart Valve Devices Market: A recent study by Fact.MR on the Heart Valve Devices Market offers a 10-year forecast analysis for the period 2020 to 2025. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Brain Tissue Oxygen Monitoring Systems Market: Fact.MR’s extensive coverage on the Brain Tissue Oxygen Monitoring Systems Market offers in-depth insights about the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Tracheobronchial Suction Catheters Market: The Tracheobronchial Suction Catheters Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.

Research Insight: https://www.factmr.com/report/3416/tricuspid-valve-repair-market

Content Source: https://www.factmr.com/media-release/1358/global-tricuspid-valve-repair-market

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852

SourceFACT.MR
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy